Medicine
fromThe Atlantic
1 month agoA New Class of Drugs Is Pushing the Limits of Weight Loss
New amylin-based and combined amylin–GLP-1 drugs can produce greater weight loss with fewer bothersome side effects, expanding medical obesity treatment options.